Skip to main content

Professor Janaka Karalliedde

image of Professor Janaka Karalliedde
Image: Professor Janaka Karalliedde

Guy's and St Thomas Hospital London and King's College London, London

Professor Janaka Karalliedde is Professor of Diabetes, in the School of Cardiovascular Medicine and Metabolic Sciences, King's College London and Consultant Physician in Diabetes and Endocrinology at Guy’s and St Thomas Hospital London.

Janaka graduated with a distinction in medicine from the University of London and was awarded UK Medical Research Council Clinical Research Training Fellowship and PhD by the University of London for research on the pathophysiology and treatment of cardiovascular disease and kidney disease in diabetes.
He has published widely in the subject of diabetic kidney disease and cardiovascular disease and has been awarded research grants from the UK Medical Research Council, Diabetes UK, European Foundation for the Study of Diabetes, NIHR, and type 1 breakthrough. Janaka has led on UK Kidney Association (UKKA) and Association of British Clinical Diabetologists (ABCD) diabetic kidney disease guidelines and is the co-chair of this working group. He the associate editor for European Federation of Internal Medicine (EFIM) education academy leading on cardio-renal-metabolic education, an associate editor for Diabetologia the journal of the European Association for the study of diabetes (EASD) and a member of the EASD teaching and education committee.
Janaka is an active clinician, with expertise in managing patients with renal and cardio-vascular complications related to diabetes. He runs specialist clinics for patients with diabetic kidney and vascular complications at Guy’s and St Thomas Hospital and has led the development of cardio-renal community diabetes clinics in South London that are focussed on early identification and interventions in people with diabetes at high risk of cardiovascular and kidney disease. More recently he has led multi-award (HSJ, Quality in Care) winning programme on data led risk stratification and clinical prioritisation that is now embedded in routine care.